CA2028121A1 - Anticorps monoclonaux humains contre le virus de l'immunodeficience humaine - Google Patents

Anticorps monoclonaux humains contre le virus de l'immunodeficience humaine

Info

Publication number
CA2028121A1
CA2028121A1 CA002028121A CA2028121A CA2028121A1 CA 2028121 A1 CA2028121 A1 CA 2028121A1 CA 002028121 A CA002028121 A CA 002028121A CA 2028121 A CA2028121 A CA 2028121A CA 2028121 A1 CA2028121 A1 CA 2028121A1
Authority
CA
Canada
Prior art keywords
human
monoclonal antibody
antibody
directed against
monoclonal antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002028121A
Other languages
English (en)
Inventor
Susan Zolla-Pazner
Miroslaw K. Gorny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University NYU
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2028121A1 publication Critical patent/CA2028121A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1143—Gag-pol proteins, e.g. p17or p24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CA002028121A 1989-02-28 1990-02-28 Anticorps monoclonaux humains contre le virus de l'immunodeficience humaine Abandoned CA2028121A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31674489A 1989-02-28 1989-02-28
US316,744 1989-02-28
US40998689A 1989-09-19 1989-09-19
US409,986 1989-09-19

Publications (1)

Publication Number Publication Date
CA2028121A1 true CA2028121A1 (fr) 1990-08-29

Family

ID=26980569

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002028121A Abandoned CA2028121A1 (fr) 1989-02-28 1990-02-28 Anticorps monoclonaux humains contre le virus de l'immunodeficience humaine

Country Status (5)

Country Link
EP (1) EP0418347A4 (fr)
JP (1) JPH04505099A (fr)
AU (2) AU651794B2 (fr)
CA (1) CA2028121A1 (fr)
WO (1) WO1990009805A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033915A1 (fr) 1996-03-12 1997-09-18 Ovoimmun Gmbh Anticorps aviaires, vitellins diriges contre les antigenes du vih
DE19809785C2 (de) * 1998-03-08 2000-02-10 Wolfgang Bergter Radioimmunpharmakon zur Behandlung der HIV-1-Infektion
FR2777285B1 (fr) * 1998-04-10 2000-05-19 Bio Merieux Ligand peptidique presentant une affinite specifique vis-a-vis de la proteine p24 du retrovirus hiv-1
US7744887B2 (en) 2004-06-01 2010-06-29 Merck & Co., Inc. Human antibodies interacting with HIV gp41
WO2017093985A1 (fr) 2015-12-05 2017-06-08 Centre Hospitalier Universitaire Vaudois Agents de liaison au vih

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930000189B1 (ko) * 1984-10-18 1993-01-11 앵스뛰띠 빠스뙤르 임파선증과 후천성 면역 결핍증 바이러스의 항원을 제조하는 방법 및 이 항원에 대한 항체의 생산 방법
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus

Also Published As

Publication number Publication date
AU651794B2 (en) 1994-08-04
AU5188590A (en) 1990-09-26
AU5225693A (en) 1994-03-03
JPH04505099A (ja) 1992-09-10
EP0418347A4 (en) 1994-12-14
EP0418347A1 (fr) 1991-03-27
WO1990009805A1 (fr) 1990-09-07
AU680836B2 (en) 1997-08-14

Similar Documents

Publication Publication Date Title
Gorny et al. Generation of human monoclonal antibodies to human immunodeficiency virus.
EP0308936B1 (fr) Hétéroconjugués d'anticorps pour tuer des cellules infectées par VIH
EP0459779B1 (fr) Réactifs immunologiques réagissant avec un épitope constant du virus immunodéficient humain du type I (HIV-I) GP120 et méthodes d'utilisation
Fung et al. Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120
AU632475B2 (en) Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
Robinson et al. Identification of conserved and variant epitopes of human immunodeficiency virus type 1 (HIV-1) gp120 by human monoclonal antibodies produced by EBV-transformed cell lines
WO1990010457A1 (fr) Procede de traitement d'infections relatives au vih a l'aide d'immunotoxines
US5087557A (en) Human monoclonal antibody to lymphadenopathy-associated virus
US5731189A (en) Human monoclonal antibodies to human immunodeficiency virus
US5854400A (en) Monoclonal antibodies which neutralize HIV-1 infection
US5807992A (en) HIV-2 transmembrane glycoprotein homodimer (gp 80)
EP0251612B1 (fr) Anticorps monoclonal humain contre le virus associé à la lymphadénopathie
US5783670A (en) Monoclonal antibodies specific for HIV and the hybridomas for production thereof
Cotropia et al. A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates
US6241986B1 (en) Human monoclonal antibodies to the CD4-binding domain of HIV, uses thereof and synergistic neutralization of HIV
CA2058630A1 (fr) Anticorps monoclonaux humains pour vih- 1 mn gp 120
AU651794B2 (en) Human monoclonal antibodies to human immunodeficiency virus
Boyd et al. B cell responses to HIV and the development of human monoclonal antibodies
Lake et al. Generation and characterization of a human monoclonal antibody that neutralizes diverse HIV-1 isolates in vitro
US5798251A (en) Antibody and antibody derivative immunoreagents reactive with a conserved epitope of Human Immunodeficiency Virus Type 1 (HIV-1) gp 120
WO1991006575A1 (fr) Anticorps monoclonal humain specifique du vih-1
EP0400245B1 (fr) Protéines et glycoprotéines du retrovirus HIV-2 EHO, anticorps dirigés contre eux, application pour le diagnostic
KR920001772B1 (ko) 포유류 중의 HIV-억제 항체 유도성 사람 면역 결핍 바이러스(HIV) env-암호화된 펩타이드
HK212896A (en) Proteins and glycoproteins of the hiv-2 eho retrovirus antibodies directed against them - application for the diagnosis
WO1992012731A1 (fr) Antigenes gag glycosyles et anticorps qui reagissent avec des cellules vivantes exprimant ces antigenes

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued